Shenzhen Salubris Pharmaceuticals Co Ltd (002294) — Cash Flow Quality Index
Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Cash Flow Quality Index of 1.86x as of September 2025. Operating cash flow of CN¥400.70 Million exceeds net income of CN¥215.63 Million, indicating high earnings quality where cash backs reported profits. Explore 002294 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shenzhen Salubris Pharmaceuticals Co Ltd Cash Flow Quality Index (2006–2024)
Historical Cash Flow Quality Index for Shenzhen Salubris Pharmaceuticals Co Ltd across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Shenzhen Salubris Pharmaceuticals Co Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)
Year-by-year earnings quality comparison for Shenzhen Salubris Pharmaceuticals Co Ltd. For live market cap and the full company financial profile, see 002294 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.96x | CN¥1.19 Billion | CN¥605.16 Million | ▲ +30.7% |
| 2023 | 1.50x | CN¥869.79 Million | CN¥580.07 Million | ▼ -2.0% |
| 2022 | 1.53x | CN¥970.80 Million | CN¥634.22 Million | ▼ -31.8% |
| 2021 | 2.24x | CN¥1.18 Billion | CN¥528.32 Million | ▼ -91.8% |
| 2020 | 27.41x | CN¥1.37 Billion | CN¥50.13 Million | ▲ +1140.6% |
| 2019 | 2.21x | CN¥1.51 Billion | CN¥681.84 Million | ▲ +139.7% |
| 2018 | 0.92x | CN¥1.34 Billion | CN¥1.45 Billion | ▼ -9.1% |
| 2017 | 1.01x | CN¥1.46 Billion | CN¥1.44 Billion | ▼ -1.7% |
| 2016 | 1.03x | CN¥1.43 Billion | CN¥1.39 Billion | ▲ +24.1% |
| 2015 | 0.83x | CN¥1.06 Billion | CN¥1.27 Billion | ▼ -11.7% |
| 2014 | 0.94x | CN¥982.25 Million | CN¥1.04 Billion | ▲ +17.3% |
| 2013 | 0.80x | CN¥668.52 Million | CN¥833.26 Million | ▼ -2.2% |
| 2012 | 0.82x | CN¥521.21 Million | CN¥635.55 Million | ▲ +22.1% |
| 2011 | 0.67x | CN¥272.32 Million | CN¥405.45 Million | ▲ +27.9% |
| 2010 | 0.53x | CN¥186.65 Million | CN¥355.51 Million | ▼ -15.7% |
| 2009 | 0.62x | CN¥134.28 Million | CN¥215.68 Million | ▼ -6.5% |
| 2008 | 0.67x | CN¥77.89 Million | CN¥116.94 Million | ▼ -7.7% |
| 2007 | 0.72x | CN¥52.75 Million | CN¥73.14 Million | ▲ +105.7% |
| 2006 | 0.35x | CN¥12.00 Million | CN¥34.24 Million | — |